Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11530192 Crystalline and salt forms of PPAR agonist compounds

Patent 11530192 was granted and assigned to Mitobridge on December, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

This disclosure relates to salt forms of compounds capable of activating PPARδ for use in drug substance and drug product development, and related compositions and methods.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11530192 Crystalline and salt forms of PPAR agonist compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.